Literature DB >> 22977475

Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.

Masakazu Tanaka1, Takayuki Nitta, Binlian Sun, Jun-Ichi Fujisawa, Masanao Miwa.   

Abstract

Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia and HTLV-1-associated myelo-pathy/tropical spastic paraparesis. HTLV-1 is mainly transmitted through blood transfusion and breastfeeding, but viral proliferation in the body in vivo shortly after transmission is not well understood. To investigate whether the route of infection influences the early stages of viral proliferation, we inoculated BALB/c mice with MT-2 cells, an HTLV-1-producing human T-cell line, via different routes, and evaluated the proviral load and humoral immune responses. One month after infection, the provirus was detected in most organs of the mice infected intraperitoneally, and substantial proviral loads were detected in the peripheral blood and secondary lymphoid organs. In contrast, the mice infected intravenously and orally showed low proviral loads, and the provirus distribution was limited to the spinal cord among the intravenously inoculated mice and to the liver among the perorally inoculated mice. Mice infected intraperitoneally also exhibited higher interleukin-2 production than the mice infected intravenously or orally, or than the uninfected control mice, while anti-HTLV-1 antibody titers were comparable between the mice infected intraperitoneally and intravenously. These results demonstrate that the route of primary HTLV-1 infection influences the establishment of HTLV-1-infected cell proliferation and the cell reservoir in mice.

Entities:  

Year:  2010        PMID: 22977475      PMCID: PMC3440678          DOI: 10.3892/etm.2010.179

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.

Authors:  Kathryn S Jones; Salem Akel; Cari Petrow-Sadowski; Ying Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

2.  In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.

Authors:  Takeo Ohsugi; Ryouichi Horie; Toshio Kumasaka; Akira Ishida; Takaomi Ishida; Kazunari Yamaguchi; Toshiki Watanabe; Kazuo Umezawa; Toru Urano
Journal:  Carcinogenesis       Date:  2005-04-14       Impact factor: 4.944

3.  Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.

Authors:  Atsuhiko Hasegawa; Takashi Ohashi; Shino Hanabuchi; Hirotomo Kato; Fumiyo Takemura; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Subversion of the innate immune system by a retrovirus.

Authors:  Brooke A Jude; Yelena Pobezinskaya; Jennifer Bishop; Susannah Parke; Ruslan M Medzhitov; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Nat Immunol       Date:  2003-05-05       Impact factor: 25.606

5.  Source and route of exposure influence infectivity of a molecular clone of human T cell leukemia virus type I.

Authors:  R M Simpson; T M Zhao; B Schmidt Hubbard; W Said; T J Kindt
Journal:  AIDS Res Hum Retroviruses       Date:  1998-05-20       Impact factor: 2.205

6.  Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.

Authors:  H Kato; Y Koya; T Ohashi; S Hanabuchi; F Takemura; M Fujii; H Tsujimoto; A Hasegawa; M Kannagi
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.

Authors:  M Popovic; G Lange-Wantzin; P S Sarin; D Mann; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.

Authors:  V Panoutsakopoulou; C S Little; T G Sieck; E P Blankenhorn; K J Blank
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.

Authors:  D Persaud; J L Muñoz; S L Tarsis; E S Parks; W P Parks
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase.

Authors:  Takayuki Nitta; Masakazu Tanaka; Binlian Sun; Eiji Sugihara; Mako Kimura; Yuhei Kamada; Hideto Takahashi; Shuji Hanai; Shi-Wen Jiang; Jun-ichi Fujisawa; Masanao Miwa
Journal:  Cancer Sci       Date:  2008-02-27       Impact factor: 6.716

View more
  1 in total

1.  The effect of HTLV1 infection on inflammatory and oxidative parameters in the liver, kidney, and pancreases of BALB/c mice.

Authors:  Saeed Niazmand; Arezoo Gowhari Shabgah; Sara Hosseinian; Jamshid Gholizadeh Navashenaq; Ali Kamali; Mohammad Reza Khazdair; Yousef Baghcheghi; Mahdiyeh Hedayati-Moghadam
Journal:  Physiol Rep       Date:  2022-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.